Biotechs build a GxP system, then the work moves to e-mail at the first handoff. Which should come first, the system or the documents?
Good software makes you more capable — able to do work that was closed to you, or do it far better. What that means across a regulatory team’s whole job.
What an eCTD study tagging file (STF) is, when FDA expects one, how file tags work, the common validation findings, and what replaces STFs in 4.0.
Took over an eCTD application from another vendor or tool? How to check its history, what usually goes wrong, and how to fix it safely.
Build an eCTD publishing team or outsource it? How to decide on volume, risk and skills, and what to ask a publishing partner before you sign.
Filing your first IND in eCTD? A sequence 0000 checklist: application number, FDA gateway, Module 1, document plan, validation and the 30-day clock.
How to decide eCTD document granularity for Modules 2 to 5, and why splitting documents well makes every later sequence smaller and clearer.
New, replace, append and delete: how eCTD lifecycle operations build the current view, the mistakes that confuse reviewers, and what changes in 4.0.
High, medium, low; pass/fail; error and warning. What each agency’s eCTD validation severity means and which findings stop a submission.
How to read an eCTD validation report: what each severity means, how to group findings by cause, and how to prove a fix worked before you submit.